Guangzhou, China

Xiyue Chen

This inventor holds 1 USPTO granted patent. Top assignee: South China Agricultural University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiyue Chen. Retrieved from https://idiyas.com/inventor/xiyue-chen-o38nx8g8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Xiyue Chen

Introduction

Xiyue Chen is an accomplished inventor based in Guangzhou, China. He has made significant contributions to the field of avian influenza research. His work focuses on the development of innovative solutions to combat viral infections in poultry.

Latest Patents

Xiyue Chen holds a patent titled "Construction and Application of Recombinant H5N8 Subtype Avian Influenza Virus Carrying Maple Fluorescence Reporter Gene." This patent represents a crucial advancement in the study and management of avian influenza.

Career Highlights

Xiyue Chen is affiliated with South China Agricultural University, where he conducts research and develops new methodologies in virology. His dedication to scientific inquiry has led to important findings that benefit both agriculture and public health.

Collaborations

Xiyue Chen has collaborated with notable colleagues, including Manman Dai and Wei Song. These partnerships enhance the research efforts and contribute to the advancement of knowledge in their field.

Conclusion

Xiyue Chen's innovative work in avian influenza research exemplifies the impact of dedicated scientists on public health and agriculture. His contributions are vital in the ongoing fight against viral diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…